{ "cik": 1622229, "cik_padded": "0001622229", "entityName": "Cogent Biosciences, Inc.", "fiscal_years": [ { "accn": "0001193125-26-053334", "filed": "2026-02-17", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1554000.0, "cash": 312012000.0, "eps_diluted": -2.16, "free_cash_flow": -265998000.0, "net_income": -328937000.0, "operating_cash_flow": -264444000.0, "operating_income": -333363000.0, "stockholders_equity": 636371000.0, "total_assets": 937607000.0, "total_liabilities": 301236000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4733653796291786, "roa_avg2y": -0.5198509685856634, "roa_period_end": -0.3508260923819895, "roe_avg2y": -0.7369840823519, "roe_period_end": -0.5168950187862111 } }, { "accn": "0001193125-26-053334", "filed": "2026-02-17", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 573000.0, "cash": 98165000.0, "eps_diluted": -1.94, "free_cash_flow": -208364000.0, "net_income": -255859000.0, "operating_cash_flow": -207791000.0, "operating_income": -275939000.0, "stockholders_equity": 256286000.0, "total_assets": 327898000.0, "total_liabilities": 71612000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.27942220800199774, "roa_avg2y": -0.7978950158653434, "roa_period_end": -0.7803005812783244, "roe_avg2y": -0.9953898943371563, "roe_period_end": -0.9983338926043561 } }, { "accn": "0001193125-26-053334", "filed": "2026-02-17", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2796000.0, "cash": 53229000.0, "eps_diluted": -1.94, "free_cash_flow": -156420000.0, "net_income": -192410000.0, "operating_cash_flow": -153624000.0, "operating_income": -208130000.0, "stockholders_equity": 257802000.0, "total_assets": 313437000.0, "total_liabilities": 55635000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.21580515279167733, "roa_avg2y": -0.6264906462709626, "roa_period_end": -0.6138713680899192, "roe_avg2y": -0.7493520427934112, "roe_period_end": -0.7463479724750002 } }, { "accn": "0001193125-26-053334", "filed": "2026-02-17", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6863000.0, "cash": 139886000.0, "eps_diluted": -1.73, "free_cash_flow": -125501000.0, "net_income": -140241000.0, "operating_cash_flow": -118638000.0, "operating_income": -147839000.0, "stockholders_equity": 255735000.0, "total_assets": 300810000.0, "total_liabilities": 45075000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.17625667194556865, "roa_avg2y": -0.5263294189175496, "roa_period_end": -0.4662112296798644, "roe_avg2y": -0.5968730781262302, "roe_period_end": -0.5483840694468883 } }, { "accn": "0000950170-25-026115", "filed": "2025-02-25", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1719000.0, "cash": 219684000.0, "eps_diluted": -1.87, "free_cash_flow": -60482000.0, "net_income": -72273000.0, "operating_cash_flow": -58763000.0, "operating_income": -75551000.0, "stockholders_equity": 214184000.0, "total_assets": 232092000.0, "total_liabilities": 17908000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08361035371456318, "roa_avg2y": -0.2992621240227905, "roa_period_end": -0.31139806628405975, "roe_avg2y": -0.3220355975591009, "roe_period_end": -0.33743416875210097 } }, { "accn": "0001564590-22-010238", "filed": "2024-02-26", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 242190000.0, "net_income": -74808000.0, "operating_cash_flow": -35850000.0, "operating_income": -82199000.0, "stockholders_equity": 234667000.0, "total_assets": 250916000.0, "total_liabilities": 16249000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06924279937102362, "roa_avg2y": -0.49815708249677865, "roa_period_end": -0.29813961644534426, "roe_avg2y": -0.5615604907874143, "roe_period_end": -0.3187836380914232 } }, { "accn": "0001564590-22-010238", "filed": "2022-03-15", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 33000.0, "cash": 37424000.0, "free_cash_flow": -41547000.0, "net_income": -31833000.0, "operating_cash_flow": -41514000.0, "operating_income": -32178000.0, "stockholders_equity": 31762000.0, "total_assets": 49423000.0, "total_liabilities": 17661000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5560418109690826, "roa_avg2y": -0.47038049501292944, "roa_period_end": -0.6440928312728892, "roe_avg2y": -0.6920518283403626, "roe_period_end": -1.0022353756060702 } }, { "accn": "0001564590-21-013325", "filed": "2021-03-16", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 549000.0, "cash": 55671000.0, "free_cash_flow": -33038000.0, "net_income": -34532000.0, "operating_cash_flow": -32489000.0, "operating_income": -36005000.0, "stockholders_equity": 60234000.0, "total_assets": 85927000.0, "total_liabilities": 25693000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.42655310953946274, "roa_avg2y": -0.5114260748507872, "roa_period_end": -0.40187601103262066, "roe_avg2y": -6.064629434492448, "roe_period_end": -0.5732974731879005 } }, { "accn": "0001564590-20-013188", "filed": "2020-03-26", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 912000.0, "cash": 28270000.0, "free_cash_flow": -26747000.0, "net_income": -25492000.0, "operating_cash_flow": -25835000.0, "operating_income": -26152000.0, "stockholders_equity": -48846000.0, "total_assets": 49115000.0, "total_liabilities": 20810000.0 }, "period_end": "2017-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_period_end": -0.5190267738979945, "roe_avg2y": 0.6932448602197324 } }, { "accn": "0001193125-19-089299", "filed": "2019-03-28", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -24698000.0 }, "period_end": "2016-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-053334", "filed": "2026-02-17", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001622229.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001622229.json" }, "ticker": "COGT" }